Thalys Medical Technology Group Inc. (603716.SS) SHH

26.24

+0.51(+1.98%)

Updated at October 20 11:30AM

Currency In CNY

Valuation

Market Cap1.39B
Enterprise Value2.08B
P/E Ratio-20.2
PEG Ratio1.56
Price/Sales Ratio3.4
Price/Book Ratio6
Enterprise/Revenue3.88
Enterprise/EBITDA-33.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.1

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.27

Income Statement

Revenue1.81B
Revenue/Share6.92
Gross Profit331.88M
EBITDA-37.9M
Net Income-209.24M
Diluted EPS-1.09

Balance Sheet

Total Cash123.22M
Total Cash/Share0.6
Total Debt812.34M
Total Debt/Equity0.93
Current Ratio1.73
Book Value Per Share4.15

Price History

52-Week Change277.27
52-Week High38.12
52-Week Low6.4
Moving Average 50 Days28.66
Moving Average 200 Days17.28

Statistics

Average Volume38.35M
Shares Outstanding186.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.06
Last Split Factor5:2
Last Split DateApril 25, 2018